Key Insights

Highlights

Success Rate

56% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 77/100

Termination Rate

23.5%

4 terminated out of 17 trials

Success Rate

55.6%

-31.0% vs benchmark

Late-Stage Pipeline

24%

4 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results56% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (4)
P 2 (1)
P 3 (2)
P 4 (2)

Trial Status

Completed5
Terminated4
Recruiting4
Unknown3
Not Yet Recruiting1

Trial Success Rate

55.6%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT06870409Phase 3RecruitingPrimary

Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis

NCT06563609Not ApplicableTerminated

Combined Rehabilitation and Nutritional Support vs. Standard Care in In-Hospital Endocarditis Treatment

NCT06250985Phase 3RecruitingPrimary

New Treatment of Cardiac Device Infections; Immediate Reimplantation After Removal of Infected System

NCT04840225Completed

Anemia in Patients With Endocarditis

NCT06434012Recruiting

Barts Endocarditis Research Registry

NCT02979951Recruiting

Fosfomycin I.v. for Treatment of Severely Infected Patients

NCT04222257Phase 4TerminatedPrimary

Short-course Antibiotic Treatment in Gram-positive Cocci Infective Endocarditis

NCT05644990Unknown

T2MR PCR Detection of ESKAPE Pathogens in Patients With Pyogenic Spondylodiscitis and Infective Endocarditis

NCT05613933Not ApplicableNot Yet RecruitingPrimary

Effectiveness of Antibiotic Prophylaxis of Infective Endocarditis for Invasive Dental Procedures in Patients With Prosthetic Heart Valves and/or History of Infective Endocarditis

NCT05522764Unknown

Predictors of Infective Endocarditis Among Patients Managed for Staphylococcus Aureus Bacteremia, Particularly Staphylococcus Aureus Bacteriuria, and Time to Blood Culture Positivity

NCT05152225UnknownPrimary

Neurological Complication of Infective Endocarditis: A Prospective Multi-site Cohort Study

NCT03306225CompletedPrimary

Characterization of Endocarditis to Streptococci and Impact of the CMI on the Future of the Patients

NCT03048643Not ApplicableCompletedPrimary

Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis

NCT00695903Phase 2TerminatedPrimary

Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia

NCT00401960Phase 4TerminatedPrimary

Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.

NCT00524212CompletedPrimary

How to Improve Diagnosis in Infective Endocarditis

NCT00144885Not ApplicableCompletedPrimary

IMAGE-Endocarditis: Resonance Magnetic Imaging at the Acute Phase of Endocarditis

Showing all 17 trials

Research Network

Activity Timeline